The three-dimensional electroluminescence display comprises a main body and an electroluminescence device. The method of the present invention comprises administration of an oxo-clopidogrel or its derivative of the Formula IIA in its free or pharmaceutically acceptable salt form for alleviating the symptoms of thrombosis or embolism by inhibiting blood platelet aggregation. By using a catalyst composition including the transition metal complex, a linear low density polyolefin copolymer having a high molecular weight and a very low density polyolefin copolymer having a density of 0. An apparatus for assembling a stator core has a plurality of radially disposed and radially movable jigs for holding the segmented cores.